|
End-of-day quote
Berne S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 135.88 CHF | -2.33% |
|
-1.13% | -6.19% |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09-30 | Major drugmakers turn to China for licensing deals | RE |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 32.9x | 20.9x | 0.62x | 11.93x | 24.23x | 25.63x | 0.6% | 1,031B | ||
| 29.45x | 7.39x | -1.59x | 6.54x | 18.31x | 20.57x | 2.02% | 638B | ||
| 33.1x | -476.37x | 0.14x | 7.75x | 16.02x | 16.7x | 2.65% | 462B | ||
| 105.72x | 7.4x | -1.3x | 5.91x | 25.05x | 33.07x | 2.35% | 359B | ||
| 19x | 6.94x | 1.3x | 4.63x | 11.48x | 12.72x | 2.87% | 335B | ||
| 20.37x | 5.77x | -9.76x | 5.28x | 13.08x | 13.97x | 3.03% | 273B | ||
| 20.79x | 4.68x | 1.04x | 4.31x | 12.28x | 12.92x | 2.05% | 253B | ||
| 26.62x | 20.14x | 2.36x | 6.92x | 12.32x | 15.88x | 2.39% | 228B | ||
| -45.08x | 11.1x | 0.3x | 6.57x | 25.65x | 62.22x | 2.21% | 185B | ||
| 11.34x | 4.74x | -3.7x | 4.12x | 8.57x | 10.03x | 4.43% | 170B | ||
| 17.99x | 1.85x | 1.08x | 3.37x | 8.64x | 9.83x | 6.04% | 163B | ||
| 53.73x | 8.48x | -1.47x | 9.58x | 32.86x | 26.44x | -.--% | 133B | ||
| 11.12x | 5.24x | 0.18x | 3.13x | 8.15x | 8.78x | 4.05% | 127B | ||
| 21.88x | -41.54x | 13.23x | 0.24x | 13.8x | 14.76x | 0.43% | 99.55B | ||
| 14.22x | 4.53x | -1.64x | 2.79x | 8.25x | 9.18x | 3.8% | 97.46B | ||
| 11.57x | 1.18x | -6.12x | 2.07x | 6.69x | 7.4x | 5.86% | 98.83B | ||
| -22.96x | 13.19x | -1.48x | 34.85x | -22.64x | -21.01x | -.--% | 76.88B | ||
| 17.28x | 2.3x | 2.98x | 4.04x | 9.51x | 11.13x | 0.51% | 75.72B | ||
| 23.38x | 1.97x | -14.93x | 3.16x | 11.03x | 18.33x | 1.7% | 68.18B | ||
| Average | 21.18x | -20.53x | -0.99x | 6.69x | 12.80x | 16.24x | 2.47% | 256.48B | |
| Weighted average by Cap. | 28.74x | -36.71x | -0.64x | 7.32x | 16.82x | 19.93x | 2.18% |
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
- Sector AstraZeneca PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















